Tango Therapeutics Files Prospectus For Up To $400M Common Stock Offering
Up to $400,000,000Common StockWe have previously entered into a Sales Agreement, or the sales agreement, with Leerink Partners LLC, or Leerink Partners, dated November 21, 2025, relating to the sale of shares of our
Tango Therapeutics is planning to sell new shares of their company stock to raise up to $400 million. When a company does this, it means they need cash for their work, so watch how the company uses that money and whether investors still believe in their plans.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.